|
C3ORF37 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.099900E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.121500E-03 |
| Normal-vs-Stage2 |
7.185000E-03 |
| Normal-vs-Stage3 |
1.496190E-01 |
| Normal-vs-Stage4 |
3.110200E-01 |
| Stage1-vs-Stage2 |
6.271800E-01 |
| Stage1-vs-Stage3 |
6.398400E-01 |
| Stage1-vs-Stage4 |
8.370200E-01 |
| Stage2-vs-Stage3 |
4.277200E-01 |
| Stage2-vs-Stage4 |
9.254600E-01 |
| Stage3-vs-Stage4 |
6.854000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.123400E-03 |
| Normal-vs-AfricanAmerican |
1.725970E-02 |
| Normal-vs-Asian |
4.778600E-01 |
| Caucasian-vs-AfricanAmerican |
9.951600E-01 |
| Caucasian-vs-Asian |
9.372200E-01 |
| AfricanAmerican-vs-Asian |
9.246600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.055520E-03 |
| Normal-vs-Female |
6.085600E-01 |
| Male-vs-Female |
1.512070E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.600080E-02 |
| Normal-vs-Extreme_Weight |
7.281600E-03 |
| Normal-vs-Obese |
1.720230E-02 |
| Normal-vs-Extreme_Obese |
9.500300E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.243400E-01 |
| Normal_Weight-vs-Obese |
6.678400E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.879800E-01 |
| Extreme_Weight-vs-Obese |
8.091200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.794200E-01 |
| Obese-vs-Extreme_Obese |
5.681200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.593600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.360300E-02 |
| Normal-vs-Age(61-80Yrs) |
4.835800E-03 |
| Normal-vs-Age(81-100Yrs) |
8.698100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.824200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.972230E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.122400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.272000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.469800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.458000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.039200E-01 |
| Normal-VS-Type2 PRCC |
1.02250000000303E-06 |
| Normal-VS-KIRP CIMP |
3.042800E-01 |
| Normal-VS-Unclassified PRCC |
1.611540E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.74356000000042E-05 |
| Type1 PRCC-VS-KIRP CIMP |
7.495800E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
8.446500E-02 |
| Type2 PRCC-VS-KIRP CIMP |
5.239900E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
1.389230E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.771680E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.788500E-04 |
| Normal-vs-N1 |
3.814200E-01 |
| Normal-vs-N2 |
9.606800E-01 |
| N0-vs-N1 |
1.199200E-01 |
| N0-vs-N2 |
6.568600E-01 |
| N1-vs-N2 |
9.026000E-01 |
|
|
